Power Law company profile

TransThera Biosciences

Biotech & Life Sciences · Nanjing City, China · Founded 2016 · IPO 2025 Unicorn

Research and development of innovative drugs in oncology, cardiovascular, and inflammatory diseases

Valuation

$629M

Market cap · 2026

Revenue

$7.4M

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

20 investors on TransThera Biosciences's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 20 investors entered at this stage

China Structural Reform Fund

Grand Yangtze Capital

Guoxin Capital

Shenzhen Cornerstone Asset Management

BOCG Investment

Trinity Innovation Fund

Ocean Pine Healthcare Fund

Ennovation Ventures

Sixty Degree Capital

CITIC PE

Nanjing Jiangbei State-owned Assets

GP Healthcare Capital

Dunhang Capital

China Merchants Capital

Ruitong Venture Capital

GP Capital

Guolian Financial Investment Qiyuan

SDIC Venture Capital

China Renaissance

Ruihua Holdings

Global footprint

Where TransThera Biosciences has talent and traffic

Workforce by country

2 countries with
team presence

🇨🇳 China75%

🇺🇸 United States25%

2 countries shown

Web traffic by country

200 monthly visits
across markets

🇩🇪 Germany100%

Top 1 markets shown

Patent intelligence

$73M patent portfolio · 79 active families

Estimated portfolio value

$73M

11.6% of market cap · 1.6× smaller than top peer Constellation Pharmaceuticals ($116M)

79 active patent families

Where TransThera Biosciences innovates Pharmaceutical medicinePharmaceutical drugDiseaseMedicinal chemistryStereoisomerism

Where TransThera Biosciences concentrates vs peers

Each axis is a top-10 topic across TransThera Biosciences and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about TransThera Biosciences

An AI-synthesized read of the highest-engagement posts about TransThera Biosciences on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See TransThera Biosciences on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles